Canada markets closed
  • S&P/TSX

    20,157.65
    +19.30 (+0.10%)
     
  • S&P 500

    4,255.15
    +7.71 (+0.18%)
     
  • DOW

    34,393.75
    -85.85 (-0.25%)
     
  • CAD/USD

    0.8235
    0.0000 (-0.00%)
     
  • CRUDE OIL

    71.21
    +0.33 (+0.47%)
     
  • BTC-CAD

    49,071.04
    +1,324.74 (+2.77%)
     
  • CMC Crypto 200

    1,011.23
    +42.39 (+4.38%)
     
  • GOLD FUTURES

    1,868.20
    +2.30 (+0.12%)
     
  • RUSSELL 2000

    2,326.15
    -9.66 (-0.41%)
     
  • 10-Yr Bond

    1.5010
    +0.0390 (+2.67%)
     
  • NASDAQ futures

    14,146.75
    +22.00 (+0.16%)
     
  • VOLATILITY

    16.39
    +0.74 (+4.73%)
     
  • FTSE

    7,146.68
    +12.62 (+0.18%)
     
  • NIKKEI 225

    29,407.70
    +245.90 (+0.84%)
     
  • CAD/EUR

    0.6795
    +0.0002 (+0.03%)
     

Global Epilepsy Epidemiology and Patient Flow Report 2020-2035 - ResearchAndMarkets.com

·2 min read

The "Global Epilepsy Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Epilepsy Epidemiology and Patient Flow Analysis - 2021, provides Epilepsy epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Epilepsy patients, history of the disease at the population level (Epilepsy prevalence, Epilepsy incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Epilepsy patient flow: Epilepsy prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Epilepsy patients by age group, gender

  • Forecast: Epilepsy epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Epilepsy market sizing, assessing market potential, and developing drug forecast models

  • Identify Epilepsy patients segments through age groups, gender, and disease sub-types

  • Develop Epilepsy population-based health management frameworks

  • Evaluate Epilepsy market opportunities, identify target patient population

  • Align marketing decisions with the Epilepsy target population

  • Communicate leadership and health authorities about your Epilepsy target patient population

Key Topics Covered:

1. Research Methodology

2. Epilepsy Patients Definition

3. US Epilepsy Epidemiology and Patient Flow

4. Germany Epilepsy Epidemiology and Patient Flow

5. France Epilepsy Epidemiology and Patient Flow

6. Italy Epilepsy Epidemiology and Patient Flow

7. Spain Epilepsy Epidemiology and Patient Flow

8. UK Epilepsy Epidemiology and Patient Flow

9. Europe Epilepsy Epidemiology and Patient Flow

10. Japan Epilepsy Epidemiology and Patient Flow

11. Global Epilepsy Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/lgomus

View source version on businesswire.com: https://www.businesswire.com/news/home/20210511005628/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900